BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Corindus Vascular Robotics Reports Third Quarter 2017 Results

  Revenue for the third quarter of 2017 was $2.4 million compared to $0.7 million for the same period in the prior year.

  November 7, 2017

   · 

  9 min read
• Business

  Invuity Reports 2017 Third Quarter Financial Results

  Revenue was $9.6 million in the third quarter of 2017, up 13% from revenue of $8.5 million in the third quarter of 2016 driven by an increase in active accounts. Management estimates that approximately $400,000 in revenue was lost due to the impact of hurricanes.

  November 7, 2017

   · 

  10 min read
• 

  Business

  Effective Immediately: OncoSec Names Former Advaxis Exec as New CEO

  OncoSec Medical today announced the appointment of Daniel J. O’Connor as CEO of the Company.

  November 7, 2017

   · 

  6 min read
• Business

  Navidea Biopharmaceuticals Reports Third Quarter 2017 Financial Results

  Navidea reported total revenues for the quarter of $224,000.

  November 7, 2017

   · 

  12 min read
• Policy

  Caris Life Sciences Files Patent Infringement Suit Against Foundation Medicine, Inc.

  Caris is seeking damages and other relief for Foundation’s willful infringement of Caris’ patent rights by its FoundationOne, FoundationACT and FoundationOne Heme products.

  November 7, 2017

   · 

  2 min read
• Business

  Acasti Pharma Announces Dariush Mozaffarian, M.D., Dr.P.H. Principal Investigator for CaPre Phase 3 Development Program

  Dr. Mozaffarian is a renowned researcher whose widely published work focuses on how diets such as those rich in omega-3s and lifestyle can influence cardiometabolic health.

  November 7, 2017

   · 

  6 min read
• BIT Group to Display Molecular Instrumentation Solutions at AMP 2017

  The AMP Annual Meeting is recognized as the premier gathering for molecular professionals as they seek to obtain critical, analytical patient care intelligence.

  November 7, 2017

   · 

  2 min read
• Business

  Taro Provides Results for September 30, 2017

  Cash flow provided by operations for the six months ended September 30, 2017, was $138.7 million compared to $192.7 million for the six months ended September 30, 2016.

  November 7, 2017

   · 

  12 min read
• Business

  Dermira Reports Third Quarter 2017 Financial Results and Announces that FDA Accepts New Drug Application for Glycopyrronium Tosylate for the Treatment of Patients With Primary Axillary Hyperhidrosis

  The FDA’s decision on New Drug Application expected by June 30, 2018.

  November 7, 2017

   · 

  15 min read
• Deals

  Spero Therapeutics Announces Closing of Initial Public Offering

  The company has granted the underwriters a 30-day option to purchase up to 825,000 additional shares of its common stock at the initial public offering price.

  November 7, 2017

   · 

  1 min read